Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Yanagawa N"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Prognostic and predictive value of CD163 expression and the CD163/CD68 expression ratio for response to adjuvant chemotherapy in patients with surgically resected lung squamous cell carcinoma.
Autorzy:
Yanagawa N; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Shikanai S; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Sugai M; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Koike Y; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Asai Y; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Tanji T; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Sugimoto R; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Osakabe M; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Uesugi N; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Saito H; Department of Thoracic Surgery, Iwate Medical University, Yahaba-cho, Japan.
Maemondo M; Division of Pulmonary Medicine, Department of Internal Medicine, Iwate Medical University, Yahaba-cho, Japan.
Sugai T; Department of Molecular Diagnostic Pathology, Iwate Medical University, Yahaba-cho, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2023 Jul; Vol. 14 (20), pp. 1911-1920. Date of Electronic Publication: 2023 May 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/drug therapy
Carcinoma, Squamous Cell*/surgery
Carcinoma, Squamous Cell*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Lung Neoplasms*/metabolism
Humans ; Prognosis ; Chemotherapy, Adjuvant ; Lung/pathology ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
High expression of fibroblast-activating protein is a prognostic marker in non-small cell lung carcinoma.
Autorzy:
Yanagawa N; Department of Molecular Diagnostic Pathology, Iwate Medical University, Shiwa-gun, Japan.
Sugai M; Department of Molecular Diagnostic Pathology, Iwate Medical University, Shiwa-gun, Japan.
Shikanai S; Department of Molecular Diagnostic Pathology, Iwate Medical University, Shiwa-gun, Japan.
Sugimoto R; Department of Molecular Diagnostic Pathology, Iwate Medical University, Shiwa-gun, Japan.
Osakabe M; Department of Molecular Diagnostic Pathology, Iwate Medical University, Shiwa-gun, Japan.
Uesugi N; Department of Molecular Diagnostic Pathology, Iwate Medical University, Shiwa-gun, Japan.
Saito H; Department of Thoracic Surgery, Iwate Medical University, Shiwa-gun, Japan.
Maemondo M; Division of Pulmonary Medicine, Department of Internal Medicine, Iwate Medical University, Shiwa-gun, Japan.
Sugai T; Department of Molecular Diagnostic Pathology, Iwate Medical University, Shiwa-gun, Japan.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Aug; Vol. 13 (16), pp. 2377-2384. Date of Electronic Publication: 2022 Jul 11.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer-Associated Fibroblasts*/metabolism
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Biomarkers, Tumor/metabolism ; Fibroblasts/chemistry ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Humans ; Prognosis
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies